Navigation Links
ISPE Announces FDA to Co-Sponsor June CGMP Conference in Baltimore
Date:3/14/2012

TAMPA, Fla., March 14, 2012 /PRNewswire-USNewswire/ -- ISPE announced today the Food and Drug Administration (FDA) will co-sponsor the upcoming "Redefining the 'C' in 'CGMP'" Conference in Baltimore, Md. USA on 4 – 5 June 2012. The conference is the first joint ISPE-FDA conference focused on CGMP issues.

(Logo: http://photos.prnewswire.com/prnh/20120208/DC49497LOGO)

The conference will feature a new format with a number of audience-participation and interactive sessions. A Hot Topic Discussion Forum between attendees and regulators will feature discussion on critical industry issues, concerns and collaboration. A mixed panel of FDA and industry leaders will also answer the industry's most pressing questions during a moderated "Meet the Press" session. Topical plenary and education sessions will be featured throughout the two-day event.

"This first annual co-sponsored conference reflects ISPE's commitment to engaging its Members, companies and global regulatory agencies in dialog around critical problem-solving and learning," said ISPE's president and CEO Nancy Berg. "As the independent pharmaceutical manufacturing association, ISPE is dedicated to strengthening industry through relevant technical education, training and networking. This new conference hits the mark, assembling the entire supply chain to discuss industry's commitment to identifying and adopting quality and manufacturing techniques that continue to deliver a safe, consistent and available drug supply."

"FDA is very excited to be working on this joint conference," said Steven Lynn, Acting Director, FDA/CDER/Office of Compliance/ Office of Manufacturing and Product Quality (OMPQ). "Our goal is to make this a highly collaborative Agency and Industry conference, where we can come together to discuss the current and future state of CGMPs in the quest to e
'/>"/>

SOURCE ISPE
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... MC Medical, a subsidiary of Mitsubishi Corporation (MCM), ... OH medical device company, have formally agreed to ... visualization system in Japan . It is ... Japan in the latter half of 2015. ... product portfolio in endoscopic surgery market in Japan ...
(Date:8/22/2014)... , Cali ., Aug. 22, 2014 ... Papillomavirus Conference shows that a therapy being developed by Hera ... two that cause 70 percent of all cervical cancer. ... blocked the replication of HPV-16, HPV-18 and HPV-11 cells, according ... Broker , Ph.D., who presented the findings at the ...
(Date:8/22/2014)... 2014  Landauer, Inc. (NYSE: LDR ), ... and monitoring, outsourced medical physics services and high quality ... Saxelby , its President and Chief Executive Officer, will ... and as a member of the Board of Directors, ... replaced on an interim basis by Michael T. ...
Breaking Medicine Technology:MC Medical agrees to be the exclusive distributor of FloShield products in Japan 2Study shows Hera Therapeutics experimental compound shuts down human papillomavirus that causes most cervical cancer 2Landauer, Inc. Announces Executive Management Change 2
... 12, 2011 Aribex, Inc., the worldwide leader in ... Award from the internationally-known 2011 Edison Best New Product ... ceremony at the historic Capitale ballroom in New York ... recognized in the Science and Medical Handheld or Miniaturized ...
... Asante Solutions, Inc. (Asante), a medical device company focused ... mark for its Pearl Insulin Pump, the only insulin ... mark is a European proof of conformity that certifies ... Asante has begun discussions with potential distribution partners in ...
Cached Medicine Technology:NOMAD by Aribex Receives Edison Best New Product Award 2Asante Solutions, Inc. Receives CE Mark for Pearl™ Insulin Pump 2
(Date:8/22/2014)... Medicine team has found that targeted automated alerts ... infections in hospital patients with urinary catheters. In ... simplified, the rate of improvement dramatically increased. , ... need urinary catheters in the first place and ... catheters that have not been removed within a ...
(Date:8/22/2014)... (HealthDay News) -- Many Americans know little about how Ebola ... an outbreak in the United States, a new survey shows. ... that there will be a major Ebola outbreak in the ... immediate family member will get sick with the deadly virus ... of Public Health poll. However, those opinions don,t match ...
(Date:8/22/2014)... 22, 2014 Millennium Treatment Group, ... Lantana, FL, recently launched a new website. Patients, ... information can now find Millennium Treatment Group at ... went live at the beginning of July. Everything ... can be found on the website. There’s an ...
(Date:8/22/2014)... Las Vegas, NV (PRWEB) August 22, 2014 ... that teaches readers how they can use natural methods ... for years has caught the attention of Shane Michaels, ... only a condition that affects the skin, it can ... suffer from it,” reports Michaels. “The intense itching and ...
(Date:8/22/2014)... protein 11 (BIM) deletion in advanced non-small cell ... free survival (PFS) in epidermal growth factor receptor ... Asian patients. Also, BIM deletion independently predicts overall ... BIM protein can activate the programmed cell death ... BIM deletion has been detected in 12.8% of ...
Breaking Medicine News(10 mins):Health News:Penn study: Electronic alerts significantly reduce catheter-associated urinary tract infections 2Health News:Penn study: Electronic alerts significantly reduce catheter-associated urinary tract infections 3Health News:Many Americans Harbor Unfounded Fears About Ebola Outbreak: Survey 2Health News:Millennium Treatment Group Has a New Website 2Health News:Beat Eczema: Review Exposes Susan Clark’s Guide to Curing Eczema Naturally 2Health News:Deletion predicts survival in advanced non-small cell lung cancer 2
... maltreatment is associated with reductions in quality of life even ... that finds thaton averagevictims lose at least two years of ... professor Phaedra Corso and her colleagues at the Centers for ... people to assess the deficits in quality of life that ...
... Legendary music producer,and entertainment icon Quincy ... catastrophic earthquake that struck China and the ... recorded several public services,announcements for the American ... the,media ( http://www.redcross.org/QuincyJonesPSA )., (Photo: ...
... molecules fabricated in the laboratory have been shown to ... diabetes in animal models. The results of these studies ... Rangos Sr. Research Center at Childrens Hospital of Pittsburgh ... research study at Childrens Hospital, the scientists injected the ...
... N.C., May 28 Best Practices, LLC launched,this ... help,companies build more effective communication practices in the ... leading,pharmaceutical companies and interviews with district managers and ... on internal communication -- Percentage of time ...
... Sullivan was a born engineer. As a youngster, she ... with Tinker Toys. , Today, Sullivan, an assistant professor ... Merck Faculty Fellow, is applying her knowledge and talents ... materials for delivering healing drugs and gene therapies to ...
... PBM Holdings, Inc., a global,supplier of infant ... affiliate company, PBM (Guangzhou) Nutritionals Co., Ltd., has,donated ... PBM is,partnering with the Shanghai Bureau of Civil ... the Red Cross Society of China, to distribute ...
Cached Medicine News:Health News:Study: Child maltreatment victims lose 2 years of quality of life 2Health News:Study: Child maltreatment victims lose 2 years of quality of life 3Health News:Quincy Jones Lends Time and Talent to Support Red Cross Relief Efforts In China and Myanmar 2Health News:New vaccine approach prevents/reverses diabetes in lab study at Children's Hospital of Pittsburgh 2Health News:New vaccine approach prevents/reverses diabetes in lab study at Children's Hospital of Pittsburgh 3Health News:Research Study Shows That Pharmaceutical Field Sales Reps' Productivity Inhibited by Unnecessary Internal Communication 2Health News:Sullivan wins NSF Career Award for research on therapeutic drug carriers 2Health News:Sullivan wins NSF Career Award for research on therapeutic drug carriers 3Health News:PBM Companies Partner with the Red Cross to Donate Infant Formula to China Earthquake Victims 2
... Instruments were developed in surgeon's desire to ... having an instrument with the strength to ... of the bending or breaking. Arthrotek Hand ... conform to the surgeon's hand. This new ...
This optimal design addresses low-cost, simple, non-invasive ankle distraction....
... BTA stat Test is an ... qualitative detection of bladder tumor ... with bladder cancer. This test ... aid in the management of ...
... TheraTears Liquid Gel is a thicker version ... or for those who need a longer-lasting ... Liquid Gel is so long-lasting, it is ... preserved gels, there never needs to be ...
Medicine Products: